Trial Profile
Comparison of the Effects of Neostigmine With Sugammadex on Postoperative Nausea and Vomiting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 11 Jan 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 12 Nov 2014 New trial record